04:10 PM EST, 11/14/2025 (MT Newswires) -- Khurram Jamil, Chief Medical Officer, on November 13, 2025, sold 121,117 shares in Galectin Therapeutics ( GALT ) for $662,510. Following the Form 4 filing with the SEC, Jamil has control over a total of 4,479 common shares of the company, with 4,479 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1133416/000113341625000054/xslF345X05/form4.xml